文献速递抗菌药物管理

从瓶到床旁:血流感染快速诊断试验的实施与抗菌药物管理考量

From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing.
PubMed 文献 · Pharmacotherapy · 2023-05-22

本文为叙述性综述,讨论血流感染分子快速诊断技术(mRDTs)的现有与未来工具、临床微生物实验室与抗菌药物管理(AMS)项目的关系,以及优化使用的实践考量。文献显示mRDTs的临床与经济获益多在AMS积极干预下实现,AMS需与实验室紧密合作并认识其局限性。

要点

  • mRDTs的临床与经济获益多在AMS积极干预下实现。
  • AMS项目须与临床微生物实验室紧密合作以最大化mRDTs效益。
  • 未来需考虑向大型学术医学中心以外环境扩展及工具组合优化。

核心结论

  • mRDTs用于血流感染可改善抗菌治疗,但文献显示的临床与经济获益多在AMS积极干预下实现。

研究设计与样本

  • 叙述性综述,讨论现有与未来mRDTs、临床微生物实验室与AMS项目的关系及优化使用的实践考量。

主要发现

  • 大多数证明mRDTs对血流感染临床与经济获益的文献是在AMS积极干预下获得的。
  • 利用mRDTs改善血流感染抗菌治疗日益成为AMS项目活动的组成部分。

临床怎么用

  • AMS项目应与临床微生物实验室紧密合作,确保mRDTs效益最大化并认识其局限性。
  • 未来应探索向大型学术医学中心以外环境扩展及工具组合以进一步改善患者照护。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Antimicrobial stewardship (AMS) programs have been quick to adopt novel molecular rapid diagnostic technologies (mRDTs) for bloodstream infections (BSIs) to improve antimicrobial management. As such, most of the literature demonstrating the clinical and economic benefits of mRDTs for BSI is in the presence of active AMS intervention. Leveraging mRDTs to improve antimicrobial therapy for BSI is increasingly integral to AMS program activities. This narrative review discusses available and future mRDTs, the relationship between the clinical microbiology laboratory and AMS programs, and practical considerations for optimizing the use of these tools within a health system. Antimicrobial stewardship programs must work closely with their clinical microbiology laboratories to ensure that mRDTs are used to their fullest benefit while remaining cognizant of their limitations. As more mRDT instruments and panels become available and AMS programs continue to expand, future efforts must consider the expansion beyond traditional settings of large academic medical centers and how combinations of tools can further improve patient care.

来源:Pharmacotherapy,查看原文。版权归原作者所有。

引用

  1. Lapin JS, Smith RD, Hornback KM, et al. From bottle to bedside: Implementation considerations and antimicrobial stewardship considerations for bloodstream infection rapid diagnostic testing. Pharmacotherapy. 2023. PMID: 37158053. doi:10.1002/phar.2813

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。